Paper762115
Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.
Goldenberg GJ and 2 others. J Biol Chem, 1979. Cited by 118 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. Papers, record 762115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/762115
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Transport, Active | Major topic |
| Carrier Proteins | Major topic |
| Glutamine | Major topic |
| Leucine | Major topic |
| Melphalan | Major topic |
| Amino Acids | |
| Cell Line | |
| Kinetics |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41923388 | A LAT1-Compatible, Leadlike Tyrosine-Naphthoquinone Conjugate With Anticancer Activity. | Drug Dev Res | 2026 | https://conductscience.org/library/papers/41923388 | PubMed |
| 39240647 | Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson's Disease. | J Parkinsons Dis | 2024 | https://conductscience.org/library/papers/39240647 | PubMed |
| 37445504 | Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells. | J Clin Med | 2023 | https://conductscience.org/library/papers/37445504 | PubMed |
| 36979488 | Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979488 | PubMed |
| 36222265 | Red Light-Responsive Upconverting Nanoparticles for Quantitative and Controlled Release of a Coumarin-Based Prodrug. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/36222265 | PubMed |
| 35047931 | Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier. | Front Med Technol | 2021 | https://conductscience.org/library/papers/35047931 | PubMed |
| 33922721 | Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies-Current Research and Clinical Approaches. | J Clin Med | 2021 | https://conductscience.org/library/papers/33922721 | PubMed |
| 32874918 | Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria. | Mol Genet Metab Rep | 2020 | https://conductscience.org/library/papers/32874918 | PubMed |
| 32377929 | L-Type amino acid transporter 1 as a target for drug delivery. | Pharm Res | 2020 | https://conductscience.org/library/papers/32377929 | PubMed |
| 32237725 | Interindividual Differences in DNA Adduct Formation and Detoxification of 1,3-Butadiene-Derived Epoxide in Human HapMap Cell Lines. | Chem Res Toxicol | 2020 | https://conductscience.org/library/papers/32237725 | PubMed |
| 30577601 | Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30577601 | PubMed |
| 29695141 | Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29695141 | PubMed |
| 28160288 | Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28160288 | PubMed |
| 24646553 | Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma. | Ann Surg | 2015 | https://conductscience.org/library/papers/24646553 | PubMed |
| 23861613 | Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents Against Ocular HSV-1 Infections. | Ophthalmol Eye Dis | 2010 | https://conductscience.org/library/papers/23861613 | PubMed |
| 19568694 | Inner blood-retinal barrier transporters: role of retinal drug delivery. | Pharm Res | 2009 | https://conductscience.org/library/papers/19568694 | PubMed |
| 18638532 | Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells. | Int J Pharm | 2008 | https://conductscience.org/library/papers/18638532 | PubMed |
| 18472234 | Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. | Int J Pharm | 2008 | https://conductscience.org/library/papers/18472234 | PubMed |
| 18446509 | Prodrug approaches for CNS delivery. | AAPS J | 2008 | https://conductscience.org/library/papers/18446509 | PubMed |
| 15068672 | L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. | Neoplasia | 2004 | https://conductscience.org/library/papers/15068672 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/762115
GET https://conductscience.org/api/papers/v1/762115/cited_by?page=2